reason report
bottom line see risk reward mco favor
expect wcg like beat
come line ci aet could pressur
lack share buy-back like posit earn
surpris prior year develop like
posit guidanc revis margin upsid debt paydown
 favor risk adjust true-up modestli tweak
estim ci aet maintain
also adjust model wcg beyond includ
recent close meridian acquisit medic cost trend appear well
control potenti acuiti spike inpati observ
facil print like remain off-set continu weak volum
medacorp survey hospit administr conduct june
point deceler across site servic hix risk adjust
believ compani saw favor payabl true-up recent
disclosur rel guidanc like rais guidanc
convers post earn call like focu heavili
on-going disrupt sector amzn like entri drug
valu chain mega merger mix shift ambulatori also
expect discuss exchang polici drug price reform
upcom medicaid rfp includ like delay tx
re-procur final expect comment
commerci price outlook medicar advantag product bid
earn kick tuesday juli report
expect wcg beat line
aet ci see pressur lack buy-back exhibit
see medic cost trend remain stabl sector
acuiti spike inpati observ facil print
like remain off-set continu weak volum
forward commerci cost trend guidanc also suggest uptick
compani inform leerink partner llc research
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
medacorp survey hospit admin conduct june
point qoq yoy deceler across site servic ip
inpati op outpati ambulatori surgeri center
ed emerg depart averag respond expect
ip op ed util increas yoy
respect weaker histor
hix risk adjust believ compani
saw favor payabl true-up recent disclosur
rel guidanc like rais guidanc exhibit
expect particular benefit favor
prior year develop seen favor
pyd coverag compani exhibit
earn call like focu on-going disrupt
sector amzn like entri drug valu chain mega
merger mix-shift ambulatori care see deal
pillpack threat retail drug store chain though view
like partner pbm build buy
also expect discuss exchang polici freez
risk adjust right lean scotu well drug
price reform hix stabil subsid enrol
yoy mm bode well
final expect comment commerci price outlook
product bid expect sell season oct well
upcom medicaid award tx tx cancel tx
beat ep driven continu solid perform across
uhc optum
beat consensu driven stabl medic cost trend
histor higher favor prior year develop
beat consensu driven steadi fundament
medic cost trend bias toward lower end
guidanc rang /- bp maintain
consensu ep
ci leerink vs street lower
ep captur cadenc earn
ep expect ci see
pressur one timer includ lack favor risk
adjust paus buy-back
aet leerink vs street lower
ep previou expect pressur
hix retrench tougher comp risk adjust
paus buy-back
beat consensu given conserv guidanc
histori strong beat also adjust model
wcg beyond includ meridian deal close
report mostli line number compani
complet fide acquisit juli larg in-lin
estim time
quarter turnaround track guidanc revis
favor risk adjust true-up debt paydown
leerink vs street tweak
ep lower ep
maintain consensu view
calendar earn releas teleconfer coverag
gener see risk reward mco favor driven stabl medic cost trend steadi
util slow expect util growth expect wcg
like beat come line ci aet appear pressur
lack share buy-back
favor risk reward go earn
co datedayearn releaseteleconferencedial-in etprimari secondari etprimari etprimari etprimari et aug etprimari secondari estimate leerink estimate varianc con vs leerinkcon estleerink estimate varianc con vs guidancediversifi ep aet guidanc estim use forecast plu mm benefit tax reform mm dil share count healthcar
consolid estim conserv view coverag name
sg estim
see medic cost trend remain stabl spike acuiti seen inpati facil
print like off-set weak volum
forward commerci cost trend guidanc also suggest uptick util
 ci wcg provid consolid guidanceconsolid vs reportedleerink vs reportedconsensu healthcar
forward trend guidanc coverag compani indic stabl util trend
medacorp survey hospit admin conduct june point qoq yoy deceler
across site servic ip inpati op outpati ambulatori surgeri center ed
emerg depart averag respond expect ip op ed util
increas yoy respect
survey result indic yoy qoq deceler util trend compar
respond expect ip util remain yoy
mix shift op set continu
view compani payabl state upsid rel guidanc
like rais guidanc despit freez risk adjust payment
respond expect chang yoy util procedur perform ip vs op vs ltm ntminpatientoutpatientfreestand healthcar
seen usual higher prior year reserv develop among coverag expect
benefit pyd also seen favor pyd coverag
risk adjust estim mach mm risk adjust actual benefit year mm delta btw estim actual mm ep impact deltaep consensusprior year dec year dec year dec year dec year dec year dec year dec mm payabl includ estim per compani file tax rate assum calcul ep impact per amount receivable/ payabl healthcar
almost coverag compani develop favor prior period reserv
day claim payabl dcp also remain stabl sequenti
earn call like focu heavili on-going disrupt sector amzn like
entri drug valu chain mega merger mix-shift ambulatori care see deal
pillpack clear threat retail drug store chain medium term drug wholesal though
view like partner pbm build buy
also expect discuss exchang polici drug price reform hix stabil
subsid enrol yoy mm bode well lesser extent
final expect comment commerci price outlook medicar product bid expect sell
season oct well upcom medicaid award tx
reserv medic claim payabl larg cap healthcar
averag debt cap end
leerink vs street expect report strong result beat ep driven
continu solid perform across uhc optum
consensusleerinkconsensusleerink incom non consensusrevenu amort earn weighted-avg share net net ep flow oper paid repurchas expenditur guidanc investor updat guidanc updat guidanc healthcar
leerink vs street expect beat consensu driven stabl medic
cost trend histor higher favor prior year develop
incom non bp newconsensu adjust fund membership insur membership membership revenu expens invest incom expens share count guidanc healthcar
leerink vs street expect beat consensu driven steadi fundament
medic cost trend bias toward lower end guidanc rang /- bp maintain
consensu ep
leerinkconsensusleerinkconsensusleerinkconsensusrevenu incom bp guidanc feb guidanc may estimateconsensu estimateindividu membership membership pdp commerci commerci fulli insur segment group segment segment segment oper cost rate segment pre-tax incom segment pre-tax incom servic segment pre-tax incom averag share count healthcar
aet leerink vs street lower ep previou expect
aet see pressur due lack one timer includ risk adjust paus buy-back
ci leerink vs street lower ep captur cadenc
earn ep expect ci see pressur one timer includ
lack favor risk adjust lack buy-back
consensusleerinkconsensusleerinkconsensusleerinkoper revenu incom bp chang incom non bp healthcar
wcg leerink vs street expect wcg beat consensu given conserv
guidanc histori strong beat also adjust model wcg beyond
ci guidanceguid estimatesconsensu estimatesconsolid revenueyoy revenu medic membership growth medic medic health total oper expens health earn disabl life earn supplement benefit adj net incom guidanc exclud share oldrevenu net incom healthcar
leerink vs street view report mostli line number compani
complet fide acquisit juli larg in-lin estim time
wcg compani guidanc dec guidanc feb guidanc may estimatesconsensu estimatesgaap premium revenu premium revenu medicaid premium revenu medicaid premium revenu medicaid medicaid premium revenu pdp premium revenu pdp incom sg expens depreci amort effect incom tax newconsensusleerink newrevenu incom non-gaap growth healthcar
leerink vs street expect good quarter turnaround track
posit manag view may i-day risk adjust true-up offer posit guidanc
revis tx rfp delay like expand multipl
dec feb april june dayleerink estim -newconsensu estimatestot revenu expens ratio expens ratio excl acquisit relat tax share outstand compani guidanceleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensustot revenu chang net incom chang ep ex one chang chang healthcar
leerink vs street tweak ep lower ep
maintain consensu view
parametercompani guidanc guidanc guidanc may i-day leerink estimatesconsensu estimatespremium revenu fee reimburs tax revenu revenu incom revenu cost cost expens tax expens insur fee amort interest expens tax tax incom net incom share outstand guidanc consensusleerinkconsensusleerink consensusleerink revenu net incom growth healthcar
guidanc feb apr estim consensu estimatesnet oper compens expensenadepreci incom tax incom net averag share outstand guidanc million except per share amount healthcar
updat aet model report quarter better expect
 ep beat driven consolid beat despit headwind flu revenu in-lin
modestli miss estim compani provid revis outlook
despit beat medicar advantag membership grew across group individu
remain sidelin aet see growth challeng stand-alone basi given
current platform organiz state pend deal rais
ep estim maintain ep aet
current satisfi second request doj extend hsr hart-scott-rodino
wait period day request substanti complet expect anti-trust
scrutini go simultan hear cvs-aet ci-esrx
rule view aet balanc sheet good debt cap parent cash
 end pt contempl price-to-earnings ep
current share price deal valu per aet share
includ cash share per aet share
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf
valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ
exit sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
strong qualiti rais showcas underli strategi
execut new leadership team rais estim pt
meaning beat driven all-import reaffirm
medic cost trend cfo john galina assert focu price disciplin toward growth
even competit fulli insur market led pete haytaian medicar advantag
steadi stori import third player fl post close recent tuck-in
potenti nice acceler five plan membership
star medicaid also remain steadi growth driver solid perform recent fl
reprocur partnership nfp blue build-out pbm ingeniorx led
brian griffin proceed well local market share advantag state clearli
differenti offer local nation scale focus care deliveri strategi includ
own primari care asset tuck-in caremor health cfo strong
ni fuel share repurchas valuat still compel
consensu ep pt contempl price-to-earnings ep
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level free cash flow yield
ratio also inform potenti multipl expans except low ratio and/or high
free cash flow yield point potenti greater multipl expans
pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi health insur
us benefit marketplac place unforeseen top-lin margin headwind
commerci medicar advantag medicaid dual elig book busi
not-for-profit health insur price irrat commerci health benefit marketplac
acceler employ exit sponsorship health benefit us marketplac post
implement afford act
advers select public exchang protect adequ given delay true-
govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
obtain convict deep valu invest boston
investor mtg ci cfo eric palmer vice-president ir mcdowel sr dir ir alexi jone
maintain estim rais pt esrx clearli view
ci best possibl asset agenda drive afford better
outcom across broader payor mix higher probabl any-trust approv
differenti therapeut area focus specialti capabl esrx accredo combin
physician network collabor relationship expect improv
total cost care drive share gain retent deal potenti facilit
acceler move valu base care physician health system even time
outcom base contract bio-pharma risk materi esrx margin compress
potenti elimin drug rebat within medicare/medicaid drug price reform
commerci view overblown esrx retent risk health plan seen
manag deal view differenti aet-cv pro-competit
manag regulatori risk sharehold vote pend sec review doj decis
broadli ci margin flat expand segment offer upsid
commerci global supp margin expect remain high singl digit
medicar group life disabl potenti normal back guid
rang low mid singl high singl digit respect
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf
valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow
yield point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak member
util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership top
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
rais pt post solid immin close
fide success growth strategi deliv ep beat consensu
 driven beat lower estim share count partial off-set miss
sg tax rate guidanc lower driven delay fide close partial
off-set better expect perform appear conservat
rais estim growth strategi
execut remain differenti solid contract win latest fl core
compet success roll-up power envolv pbm manag
specialti servic platform risk peakish exchang margin downgrad
bullish tax reform guidanc remain hard argu best breed player
solid secular growth stori grow success across organ inorgan driver
next day june nyc
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level free cash flow yield
ratio also inform potenti multipl expans except low ratio and/or high
free cash flow yield point potenti greater multipl expans price target
base case ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board particularli
challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state contract
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain bullish either stand-alone player target retail
post decent report manag call one one convo
cfo brian kane quarter ep showcas steadi fundament
retail miss bp medic cost trend remain steadi retail
guidanc improv bp overal ep discuss suggest someth
happen howev unclear seek deeper partnership
outright merger ceo offer posit commentari clinic distribut valu
creation retail clinic locat within next retail storefront also express pride
partnership post call convo cfo brian kane suggest see
necessari payor agnost retail clinic offer see viabl busi model
share econom partner pois banner year ep
growth guidanc rais excess normal light
except tax rate polici tailwind along knd hospic
deal /tpg/welsh led consortium posit synergist leader across
senior focus health hospic market fl medicaid win also bring
squar lead dual snp player bipartisan spend legisl
cfo see immedi accret rais ep ep
consensu balanc sheet solid cf gener subsidiari
 mm excess rais pt reflect ep
growth guidanc rais expect potenti deal
per share deeper partnership announc expect continu run
attract themat senior focus buy hold invest
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ
exit sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
see sell-off print overdon reiter op rate
revis pt lower ep reflect one time season
driver underpin miss lower revenu mm
 reflect loss fl smi contract high singl low doubl digit revenu
ep partial off-set va medicaid contract expans va medicaid
robust pbm sell season benefit disrupt larg vertic deal
offer upsid bs cf strong mm cfo parent cash
mm end fuel accret tuck in share repurchas
challeng sub-scal player insignific see stand-alone carv
specialti benefit strategi still viabl immin contract risk month take
option alway remain given asset valu wcg build
specialti platform grow state medicaid ci-esrx aet-cv could also
futur potenti buyer sell meaning overdon see
opportun buy weak pt contempl price-to-earnings ep
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board particularli
challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state contract also
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
posit substant blueprint new manag
team led ceo joseph zubretski rais ep estim pt
manag compellingli articul invest thesi growth opportun
government-sponsor healthcar enhanc moh activ turnaround margin turnaround
plan across medic cost administr effici at-risk revenu enhanc thorough
credibl consensu ep re-affirmed rais
estim reflect increas net incom margin guidanc
 run rate ep accret capit deploy transform
year combin top bottom line growth expect revenu declin
loss fl nm contract rais ep reflect
increas net margin guid manag express great deal confid
least retain current region tx contract potenti top line growth
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
rais pt post strong report showcas
strength busi model re-instil confid offer favor
read-across group expect continu earn upsid rais
ep back solid quarter top line adj ep
growth yoy continu showcas strength busi model synergist
across optum uhc optum optum insight grow solid doubl digit
optum rx yoy rx script growth expand overal optum margin bp
yoy within uhc medicar remain strongest growth segment though commerci
growth expect pick multipl price-to-earnings year forward price-to-earnings
expand recent news-flow enter hospit drug suppli chain
entrench competit logist challeng similarli drug suppli chain price reform
pois manifest tame rfi hh speech presid april
also drive generalist money sidelin
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
convict wcg post meridian acquisit announc last even
rais pt meridian mm medicaid member
 member split state michigan illinoi offer geograph
diversif substanti top- bottom-lin growth integr pbm meridian
rx ice cake view also offer option enter exchang
continu stabil deal price revenu net margin
repres price-to-earnings meaning accret
includ synergi mm mm ramp next year deal
financ combin cash hand debt equiti issuanc debt
cap post transact pt repres price-to-earnings
consensu ep ep ep estim deal
point continu consolid medicaid landscap publicli trade player
includ wcg roll region player fide ny meridian
repres medicaid landscap
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
incom servic oper costsmed product oper incom incom earn growth net share dilut earn per ep ep chang growth sg ratio oper
care risk-bas risk-bas advantag medicar public servic medic part prescript drug model exhibit
humana inc incom mm except per servic oper invest expenseshealth care oper oper incom net share dilut earn per ep growth model exhibit
anthem inc incom oper expensesbenefit oper invest incom extinguish incom continu incom chang revenu model exhibit
enrol group self group fulli model exhibit
aetna inc aet incom oper invest futur ens incl pension oper oper net incom share growth revenu includ aet enrol
cigna inc ci incom mail order pharmaci invest invest gain expenseshealth care medic claim benefit order pharmaci cost good acquisit oper expens exclud special benefit continu oper incom tax net growth model exhibit
health enrol access/oth guarante guarante legaci servic great west medic membership medic membership gw model exhibit
mm except revenu exc invest expenses premium oper adjust ssi abd icaid icar model exhibit
except per oper tax contract oper incom continu net incom net ep ex-on growth model exhibit
centen corpor incom statement except oper tax health insur sale firstguard cnc-hnt transact incom net incom net averag share ep dilut growth net profit growth model exhibit
magellan earn modelamt mm ex per share chang cost care oper oper profit compens fair valu conting liabil continu oper tax min incom cont op min cont net net net
